Lindsey Rolfe, See Remarks at Clovis Oncology, Inc. (CLVS), sold 1,728 shares at $5.68 ($10K) on 2020-12-21, disclosed to the SEC on 2020-12-23.
Seasonal sale ($10k) by See Remarks — this insider has traded CLVS in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $8K | — | Filing → |